Skip to main content

Find Clinical Trials

Home
Conditions
Relapsed Acute Lymphoblastic Leukemia

Clinical trial condition

Relapsed Acute Lymphoblastic Leukemia

Explore clinical trials studying Relapsed Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Relapsed Acute Lymphoblastic Leukemia trial results

Completed

Palbociclib in Combo w/Chemotherapy in Peds Relapsed/Refractory Acute Lymphoblastic Leukemia

NCT04996160

Conditions: Acute Lymphoblastic Leukemia, Pediatric, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations: Lucile Packard Children's Hospital Stanford Stanford, California, United States

View Trial Details

Completed

Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia

NCT03575325

Conditions: Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL

NCT03349281

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: University of Miami Miami, Florida, United States

View Trial Details

Active, Not Recruiting

Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax

NCT05192889

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details